Press Releases

Press Releases

  1. BTG plc: Interim Results 2018

  2. BTG Sentry Bioconvertible IVC Filter 2-year Study Results Show Zero Tilt, Migration, Perforation, Fracture, or Embolization

  3. EKOS™ Control Unit 4.0 simplifies treatment of blood clots

  4. BTG plc: Directorate change

  5. BTG plc: close period update

  6. BTG Announces Replacement Policy for Expired CroFab®

  7. BTG announces global launch of the ICEfx™ Cryoablation System

  8. FDA Approves CroFab® Product Improvements

  9. BTG plc acquires Novate Medical Ltd.

  10. BTG receives not-approvable letter from the US FDA for ELEVAIR™

  11. OPTALYSE PE Results Published in JACC: Cardiovascular Interventions

  12. BTG plc: Annual General Meeting

  13. PERT Consortium and BTG Form Strategic Partnership

  14. Historical Financial Information Restated to US Dollars

  15. Result of FDA Advisory Committee vote on Elevair™ for the treatment of severe emphysema

  16. ELEVATE study aims to improve selection criteria and outcomes for patients with severe emphysema treated with the PneumRx™ Endobronchial Coil System

  17. BTG plc: Final Results 2018

  18. OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions

  19. BTG plc: close period update

  20. SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

  21. OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  22. Appointment of Non-executive Director